AMWatch

Biotekspire rejser – igen – fondsmidler i millionklassen til udvikling af smertemiddel

Det danske biotekselskab Hoba Therapeutics har landet en tocifret millioninvestering fra Innovationsfonden til den videre udvikling af et potentielt milliardomsættende smertemiddel. ”En afgørende milepæl,” lyder det fra den adm. direktør.

"Vigtigheden af en offentlig investering som Grand Solution vil kunne genkendes af alle, der forsøger eller har forsøgt at rejse kapital til tidlige projekter med høj risiko inden for hvilken som helst branche,” siger Kenneth A. Petersen, adm. direktør i Hoba Therapeutics. | Photo: Jan Bjarke Mindegaard

Der er atter en gang fondsmidler i millionklassen på vej til Ole Maaløes Vej i København, hvor Kenneth A. Petersen holder til med sit selskab Hoba Therapeutics.

Hoba Therapeutics har sammen med et konsortium af nationale og internationale samarbejdspartnere således netop landet en investering på 18,4 mio. kr. fra Innovationsfonden.

Read the whole article

Get 14 days free access.
No credit card required.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from AMWatch

The ESG market is controlled by a few big investors

Finland's largest investor holds 62 percent of shares of multi-trillion ETFs offered by iShares and 64 percent of Xtrackers' equivalent offering. Having a few investors dominating ownership in this way is not good for the vehicles' liquidity and could be a big challenge facing the sector.

"We continue to see further growth in our Nordic book of business"

DECEMBER SERIES: What were the most important developments at some of the global asset managers present on the Nordic market in 2021, and what are their expectations for the coming year? AMWatch's December series is kicked off by Head of Nordics at State Street Global Advisors, Arnaud Bruyneel. 

Related articles

Latest news

Jobs

Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch